Search

Your search keyword '"Le Marec, F."' showing total 34 results

Search Constraints

Start Over You searched for: Author "Le Marec, F." Remove constraint Author: "Le Marec, F."
34 results on '"Le Marec, F."'

Search Results

1. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

4. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

5. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

6. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

7. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

14. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

16. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

17. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

19. Infection par le VIH et vieillissement. Étude des déterminants osseux, neurocognitifs, musculaires et immunologiques. Résultats de l’étude transversale SIMBAD (ANRS CO3 aquitaine cohort)

21. Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals

22. Long-term follow-up of HIV-1 multi-drug-resistant treatment-experienced participants treated with etravirine, raltegravir and boosted darunavir: towards drug-reduced regimen? ANRS CO3 Aquitaine Cohort 2007-2018.

23. Incidence of lung and human papilloma virus-associated malignancies in HIV-infected patients.

24. Statin use and risk of severe bacterial infection in a population living with HIV: prospective cohort study of the ANRS CO3 Aquitaine Cohort 2000-2018.

25. A Low Level of Darunavir Resistance-Associated Mutation Emergence in Patients With Virological Failure During Long-term Use of Darunavir in People With HIV. The ANRS CO3 Aquitaine Cohort.

26. Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort's QuAliV ancillary study.

27. Incidence of sexually transmitted infections during pre-exposure prophylaxis for HIV: a worrying outcome at 2 years!

28. Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals.

29. Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients.

30. Incidence and Risk Factors for Severe Bacterial Infections in People Living with HIV. ANRS CO3 Aquitaine Cohort, 2000-2012.

31. Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patients.

32. Protease inhibitors exposure is not related to lung cancer risk in HIV smoker patients: a nested case-control study.

33. Switch to Rilpivirine/Emtricitabine/Tenofovir Single-Tablet Regimen of Human Immunodeficiency Virus-1 RNA-Suppressed Patients, Agence Nationale de Recherches sur le SIDA et les Hépatites Virales CO3 Aquitaine Cohort, 2012-2014.

34. Incidence and risk factors for thoracic spine pain in the working population: the French Pays de la Loire study.

Catalog

Books, media, physical & digital resources